SuperworthNRX Pharmaceuticals shares outstanding NRXP
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Mar 31, 2024
- 8.9M
- On a year earlier
- +33.2%
- more shares
NRX Pharmaceuticals had 8.9M diluted shares outstanding on average in Q1 FY24, the quarter to Mar 31, 2024.
That is 33.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2022 | 6.6M | +15% |
| FY2021 | 5.8M | +62% |
| FY2020 | 3.6M | +1169% |
| FY2019 | 281K | +7% |
| FY2018 | 263.8K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q1 FY24 | 8.9M | +33% | |
| Q3 FY23 | 8.2M | +23% | |
| Q2 FY23 | 7.3M | +11% | |
| Q1 FY23 | 6.6M | +4% | |
| Q4 FY22 | 6.6M | +15% | |
| Q3 FY22 | 6.6M | +28% | |
| Q2 FY22 | 6.6M | +55% | |
| Q1 FY22 | 6.4M | +79% | |
| Q4 FY21 | 5.8M | +62% | |
| Q3 FY21 | 5.2M | +52% | |
| Q2 FY21 | 4.2M | +16% | |
| Q1 FY21 | 3.6M | +1154% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on NRX Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.